HANMI PHARM. CO., LTD.
144Patents
108Active
144Granted
53Portfolio score
Filing activity: Feb 23, 1999 → Jul 10, 2023 · 12 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7736653B2 | Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier | Chemistry; Metallurgy | 68 | Expired |
| US7737260B2 | Protein complex using an immunoglobulin fragment and method for the preparation thereof | Chemistry; Metallurgy | 48 | Expired |
| US6515116B2 | Method of preparing form II crystals of clarithromycin | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6039981A | Antifungal oral composition containing itraconazole and process for preparing same | Human Necessities | 34 | Expired |
| US6605697B1 | Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein | Emerging Cross-Sectional Technologies | 27 | Expired |
| US8127516B2 | Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same | Performing Operations; Transporting | 22 | Active |
| US6506886B1 | Method of preparing form II crystals of clarithromycin | Chemistry; Metallurgy | 19 | Expired |
| US6444796B1 | Method of preparing form II crystals of clarithromycin | Human Necessities | 17 | Expired |
| US10894089B2 | Long-acting insulin or insulin analogue conjugate | Chemistry; Metallurgy | 17 | Active |
| USD543105S1 | Packaging box | General | 12 | Expired |
| US7476776B2 | Method for improving germline transmission efficiency of avian primordial germ cells | Chemistry; Metallurgy | 10 | Expired |
| US7470707B2 | Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation | Human Necessities | 10 | Expired |
| US10370426B2 | Triple glucagon/GLP-1/GIP receptor agonist | Human Necessities | 9 | Active |
| USD700315S1 | Pharmaceutical tablet | General | 9 | Active |
| US9724420B2 | Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC region | Chemistry; Metallurgy | 7 | Active |
| US10918736B2 | Conjugate of therapeutic enzymes | Chemistry; Metallurgy | 7 | Active |
| USD552180S1 | Label | General | 6 | Expired |
| US9220704B2 | Composite formulation comprising a tablet encapsulated in a hard capsule | Human Necessities | 6 | Active |
| US7202360B2 | Method for preparing risperidone | Chemistry; Metallurgy | 6 | Expired |
| US10400020B2 | Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist | Human Necessities | 6 | Active |
| US7718399B2 | Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment | Chemistry; Metallurgy | 5 | Active |
| US9801950B2 | Liquid formulation of long acting insulinotropic peptide conjugate | Human Necessities | 5 | Active |
| US9388165B2 | Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase | Chemistry; Metallurgy | 5 | Active |
| US6388091B1 | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one | Chemistry; Metallurgy | 4 | Expired |
| US9901621B2 | Composition for treating hyperlipidemia comprising oxyntomodulin derivative | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.